Paper21178490
Ebolavirus VP35 is a multifunctional virulence factor.
Leung DW and 3 others. Virulence, 2010. Cited by 54 papers, by iCite.
Cite this record
ConductScience Library. Ebolavirus VP35 is a multifunctional virulence factor. Papers, record 21178490. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21178490
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Ebolavirus | Major topic |
| Immune Evasion | Major topic |
| Interferons | Major topic |
| Nucleoproteins | Major topic |
| RNA, Viral | Major topic |
| Viral Core Proteins | Major topic |
| Virulence Factors | Major topic |
| Animals | |
| Hemorrhagic Fever, Ebola | |
| Humans | |
| Immunity, Innate | |
| Nucleocapsid Proteins | |
| RNA, Double-Stranded | |
| Signal Transduction |
Source PubMed
Grants12
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 AI081914 | NIAID NIH HHS | United States | R01AI081914 | PubMed and NIH | NIH RePORTER |
| R01AI059536 | NIAID NIH HHS | United States | R01AI059536 | PubMed and NIH | NIH RePORTER |
| R56AI089547 | NIAID NIH HHS | United States | R56AI089547 | PubMed and NIH | NIH RePORTER |
| U54 AI057160 | NIAID NIH HHS | United States | U54AI057160 | PubMed and NIH | NIH RePORTER |
| R56 AI089547 | NIAID NIH HHS | United States | R56AI089547 | PubMed and NIH | NIH RePORTER |
| F32 AI084324 | NIAID NIH HHS | United States | F32AI084324 | PubMed and NIH | NIH RePORTER |
| R01AI081914 | NIAID NIH HHS | United States | R01AI081914 | PubMed and NIH | NIH RePORTER |
| U54AI057160 | NIAID NIH HHS | United States | U54AI057160 | PubMed and NIH | NIH RePORTER |
| R01 AI059536 | NIAID NIH HHS | United States | R01AI059536 | PubMed and NIH | NIH RePORTER |
| U54 AI057158 | NIAID NIH HHS | United States | U54AI057158 | PubMed and NIH | NIH RePORTER |
| AI057158 | NIAID NIH HHS | United States | U54AI057158 | PubMed and NIH | NIH RePORTER |
| 1F32AI084324 | NIAID NIH HHS | United States | F32AI084324 | PubMed and NIH | NIH RePORTER |
References39
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17241710 | Status and challenges of filovirus vaccines. | Vaccine | 2007 | https://conductscience.org/library/papers/17241710 | PubMed |
| 2 | 19515768 | Ebola virus VP35 antagonizes PKR activity through its C-terminal interferon inhibitory domain. | J Virol | 2009 | https://conductscience.org/library/papers/19515768 | PubMed |
| 3 | 19694547 | Evasion of interferon responses by Ebola and Marburg viruses. | J Interferon Cytokine Res | 2009 | https://conductscience.org/library/papers/19694547 | PubMed |
| 4 | 19278996 | The RIG-I-like receptor LGP2 recognizes the termini of double-stranded RNA. | J Biol Chem | 2009 | https://conductscience.org/library/papers/19278996 | PubMed |
| 5 | 19153231 | Ebola virus protein VP35 impairs the function of interferon regulatory factor-activating kinases IKKepsilon and TBK-1. | J Virol | 2009 | https://conductscience.org/library/papers/19153231 | PubMed |
| 6 | 9765419 | Three of the four nucleocapsid proteins of Marburg virus, NP, VP35, and L, are sufficient to mediate replication and transcription of Marburg virus-specific monocistronic minigenomes. | J Virol | 1998 | https://conductscience.org/library/papers/9765419 | PubMed |
| 7 | 20071589 | Mutations abrogating VP35 interaction with double-stranded RNA render Ebola virus avirulent in guinea pigs. | J Virol | 2010 | https://conductscience.org/library/papers/20071589 | PubMed |
| 8 | 16501110 | Global suppression of the host antiviral response by Ebola- and Marburgviruses: increased antagonism of the type I interferon response is associated with enhanced virulence. | J Virol | 2006 | https://conductscience.org/library/papers/16501110 | PubMed |
| 9 | 16095644 | Homo-oligomerization facilitates the interferon-antagonist activity of the ebolavirus VP35 protein. | Virology | 2005 | https://conductscience.org/library/papers/16095644 | PubMed |
| 10 | 15805739 | Nucleocapsid-like structures of Ebola virus reconstructed using electron tomography. | J Vet Med Sci | 2005 | https://conductscience.org/library/papers/15805739 | PubMed |
| 11 | 17190786 | Antiviral signaling through pattern recognition receptors. | J Biochem | 2007 | https://conductscience.org/library/papers/17190786 | PubMed |
| 12 | 19120476 | Approaching the RNA ligand for RIG-I? | Immunol Rev | 2009 | https://conductscience.org/library/papers/19120476 | PubMed |
| 13 | 17118636 | Principles of intracellular viral recognition. | Curr Opin Immunol | 2007 | https://conductscience.org/library/papers/17118636 | PubMed |
| 14 | 16698997 | Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha/beta interferon production induced by RIG-I signaling. | J Virol | 2006 | https://conductscience.org/library/papers/16698997 | PubMed |
| 15 | 12486817 | Viruses and the type I interferon antiviral system: induction and evasion. | Int Rev Immunol | 2002 | https://conductscience.org/library/papers/12486817 | PubMed |
| 16 | 15383160 | Ebola virus: new insights into disease aetiopathology and possible therapeutic interventions. | Expert Rev Mol Med | 2004 | https://conductscience.org/library/papers/15383160 | PubMed |
| 17 | 20018665 | Ebolavirus VP35 uses a bimodal strategy to bind dsRNA for innate immune suppression. | Proc Natl Acad Sci U S A | 2010 | https://conductscience.org/library/papers/20018665 | PubMed |
| 18 | 20081868 | Structural basis for dsRNA recognition and interferon antagonism by Ebola VP35. | Nat Struct Mol Biol | 2010 | https://conductscience.org/library/papers/20081868 | PubMed |
| 19 | 16775331 | Reverse genetic generation of recombinant Zaire Ebola viruses containing disrupted IRF-3 inhibitory domains results in attenuated virus growth in vitro and higher levels of IRF-3 activation without inhibiting viral transcription or replication. | J Virol | 2006 | https://conductscience.org/library/papers/16775331 | PubMed |
| 20 | 9971816 | Comparison of the transcription and replication strategies of marburg virus and Ebola virus by using artificial replication systems. | J Virol | 1999 | https://conductscience.org/library/papers/9971816 | PubMed |
Cited by33
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 54 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42943552 | Ebola Virus Persistence in Immune-Privileged Niches: Molecular Mechanisms, Host-Virus Interactions, and Therapeutic Opportunities. | Microorganisms | 2026 | https://conductscience.org/library/papers/42943552 | PubMed |
| 42726904 | Discovering host-viral protein interactions in autophagy: A LIR discovery pipeline for identifying LC3-interacting region motifs in highly virulent viruses. | PLoS Pathog | 2026 | https://conductscience.org/library/papers/42726904 | PubMed |
| 42579070 | Ebola virus disease in the modern era: pathogenesis, therapeutic advances, vaccine strategies, and global health preparedness. | Infection | 2026 | https://conductscience.org/library/papers/42579070 | PubMed |
| 40752869 | 25 Years of Ebola Virus VP35 Research. | J Mol Biol | 2025 | https://conductscience.org/library/papers/40752869 | PubMed |
| 39858595 | The Plethora of RNA-Protein Interactions Model a Basis for RNA Therapies. | Genes (Basel) | 2025 | https://conductscience.org/library/papers/39858595 | PubMed |
| 39386170 | Aptamers: precision tools for diagnosing and treating infectious diseases. | Front Cell Infect Microbiol | 2024 | https://conductscience.org/library/papers/39386170 | PubMed |
| 37632081 | Cheminformatics Strategies Unlock Marburg Virus VP35 Inhibitors from Natural Compound Library. | Viruses | 2023 | https://conductscience.org/library/papers/37632081 | PubMed |
| 33734027 | Pathogenicity and Virulence of Ebolaviruses with Species- and Variant-specificity. | Virulence | 2021 | https://conductscience.org/library/papers/33734027 | PubMed |
| 33408171 | Transcriptional Analysis of Lymphoid Tissues from Infected Nonhuman Primates Reveals the Basis for Attenuation and Immunogenicity of an Ebola Virus Encoding a Mutant VP35 Protein. | J Virol | 2021 | https://conductscience.org/library/papers/33408171 | PubMed |
| 32992829 | To B or Not to B: Mechanisms of Protection Conferred by rVSV-EBOV-GP and the Roles of Innate and Adaptive Immunity. | Microorganisms | 2020 | https://conductscience.org/library/papers/32992829 | PubMed |
| 32493824 | Ebola Virus Inclusion Body Formation and RNA Synthesis Are Controlled by a Novel Domain of Nucleoprotein Interacting with VP35. | J Virol | 2020 | https://conductscience.org/library/papers/32493824 | PubMed |
| 31744306 | Relevance of Ebola virus VP35 homo-dimerization on the type I interferon cascade inhibition. | Antivir Chem Chemother | 2019 | https://conductscience.org/library/papers/31744306 | PubMed |
| 31155428 | Ebola Virus Replication Stands Out. | Trends Microbiol | 2019 | https://conductscience.org/library/papers/31155428 | PubMed |
| 31066445 | Ebola virus VP35 has novel NTPase and helicase-like activities. | Nucleic Acids Res | 2019 | https://conductscience.org/library/papers/31066445 | PubMed |
| 29568066 | Human transbodies that interfere with the functions of Ebola virus VP35 protein in genome replication and transcription and innate immune antagonism. | Emerg Microbes Infect | 2018 | https://conductscience.org/library/papers/29568066 | PubMed |
| 29375139 | Post-exposure treatments for Ebola and Marburg virus infections. | Nat Rev Drug Discov | 2018 | https://conductscience.org/library/papers/29375139 | PubMed |
| 28566377 | Structural Insight into Nucleoprotein Conformation Change Chaperoned by VP35 Peptide in Marburg Virus. | J Virol | 2017 | https://conductscience.org/library/papers/28566377 | PubMed |
| 27642076 | In silico and in vitro methods to identify ebola virus VP35-dsRNA inhibitors. | Bioorg Med Chem | 2016 | https://conductscience.org/library/papers/27642076 | PubMed |
| 26876165 | Differential Regulation of Interferon Responses by Ebola and Marburg Virus VP35 Proteins. | Cell Rep | 2016 | https://conductscience.org/library/papers/26876165 | PubMed |
| 26172225 | Development of Small-Molecule Antivirals for Ebola. | Med Res Rev | 2015 | https://conductscience.org/library/papers/26172225 | PubMed |
Genes15
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/21178490
GET https://conductscience.org/api/papers/v1/21178490/references?page=2